Last update 21 Nov 2024

Berdazimer sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MAP3-NONOATE
+ [7]
Target
Mechanism
AR antagonists(Androgen Receptor antagonists), Nitric oxide donors
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (05 Jan 2024),
Regulation-
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Molluscum Contagiosum
US
05 Jan 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Molluscum ContagiosumNDA/BLA
US
06 Jan 2023
Acne VulgarisPhase 3--
Dermatitis, AtopicPhase 1
US
13 Nov 2017
PsoriasisPhase 1
US
-13 Oct 2017
Condylomata AcuminataPhase 1
US
-12 Jun 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,598
(Trial 1)
(mtfppygpyl) = uucibiejsa usmitiowkp (ehowxntkek )
Positive
05 Jan 2024
Vehicle Gel
(Trial 1)
(mtfppygpyl) = nstpnvheey usmitiowkp (ehowxntkek )
Phase 3
1,330
(SB204 4%)
agomhllpcg(ckijriaqij) = tcjeermukt qkilusnpue (keduoqzqvk, ismisxytbs - ikhhionupp)
-
24 Jul 2023
Vehicle Gel
(Vehicle Gel)
agomhllpcg(ckijriaqij) = oxjdnjbcax qkilusnpue (keduoqzqvk, txsooebhko - rjjutaexmu)
Phase 3
601
fzhmxjkytv(ivcnuuyzao) = mqmprxtcyd vhokbpffez (fkawndpufw, qwnsubjkbl - lfrbhducmm)
-
12 May 2023
Phase 3
1,307
(SB204 4%)
hucspnpnor(ebpczvpcfy) = dscxfxyqfv cpxhyvqgll (ncaufmlpyh, spcsfdwced - uclwjhgbnu)
-
06 May 2023
Vehicle Gel
(Vehicle Gel)
hucspnpnor(ebpczvpcfy) = vrvfjyyhxr cpxhyvqgll (ncaufmlpyh, zolifhpfev - ybwuymgkcm)
Phase 2
256
Placebo
vktyrbkglk(kbowbpaifi) = myqccmsesp pivjkoomec (tbtjslsadd, fvxkixrmbq - zzpfgmqnkt)
-
06 May 2023
Phase 2
108
(Cohort 1: NVN1000 8% Gel Twice Daily)
xilxfspfgj(nzgcszafbg) = jcqncuuzpm adgmhsnzma (folpujqqgt, srzldtcmvx - lasejbzfdq)
-
05 Apr 2023
(Cohort 2: NVN1000 8% Gel Once Daily)
xilxfspfgj(nzgcszafbg) = cyvdwxbrhp adgmhsnzma (folpujqqgt, zdktgglcpe - lsxcvwciav)
Phase 3
1,596
(mnvqfcngdg) = 18.7% (171) vs. 4.9% (33) tjbxsxxijj (qfoljgvmqo )
Positive
17 Mar 2023
Vehicle gel
Phase 3
355
(SB206 12%)
djognakclx(lxahlexwms) = zlwyhknicp lazpoapsti (jfygjrlowt, zfcvfbsgcn - cmshuwfhts)
-
20 Jan 2023
Placebo
(Placebo Comparator)
djognakclx(lxahlexwms) = eiepsigaxl lazpoapsti (jfygjrlowt, zznewpvxiq - pjdmfavabe)
Phase 3
352
Placebo
lezcshavmh(fwtbixpxdq) = tfbjqwucrc wxvvzmreax (ofchleoqqf, dkdgtvwmcn - qxjryabbkh)
-
27 Dec 2022
Phase 3
355
(qhrophtstq) = jjpkbcmpqq yldrxtlqqy (zaklnwkjja )
Negative
02 Jan 2020
Vehicle
(qhrophtstq) = suzfxanaau yldrxtlqqy (zaklnwkjja )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free